India’s Precision Medicine: A Vision Hindered by Biobank Regulations
Precision medicine, a transformative approach to healthcare, is redefining the landscape of disease diagnosis and treatment. From groundbreaking personalised healthcare solutions to innovations like mRNA vaccines and gene-editing technologies, the field promises a new era in medical science. Yet, as India stands on the cusp of this revolution, a significant hurdle looms: the lack of robust biobank regulations.
Biobanks, essential repositories of biological samples, are critical to the success of precision medicine. These collections of blood, DNA, and tissue samples, coupled with genetic data, form the backbone of research aimed at developing targeted therapies for diseases like cancer and diabetes. However, as highlighted in a recent analysis by The Hindu, India’s inconsistent biobank regulations threaten public trust and impede progress.
The Promise of Precision Medicine
In recent years, precision medicine has witnessed remarkable achievements. Through gene therapy, researchers have restored vision in individuals with genetic mutations, while in the U.K., scientists have reversed diabetes using reengineered stem cells. The rapid development of COVID-19 vaccines using the mRNA platform, which earned a Nobel Prize, further underscores the potential of precision medicine.
India’s Growing Market
The Indian precision medicine market is burgeoning, with projections estimating a value exceeding $5 billion by 2030. Initiatives like the BioE3 policy and the approval of NexCAR19, a domestically developed CAR-T cell therapy, mark significant strides. However, the true potential of these advancements lies in aligning biobank regulations with international standards.
The Biobank Conundrum
While countries like the U.K., U.S., and Japan have comprehensive biobank regulations ensuring data protection and privacy, India’s framework remains fragmented. The absence of a single authority to regulate biobanks and the lack of penalties for misconduct create risks of ethical violations and undermine public confidence. As the ICMR guidelines illustrate, participants often consent to provide samples without clarity on data usage, raising concerns about privacy and potential discrimination.
A Path Forward
To harness the full potential of precision medicine, India must establish stringent biobank regulations. Aligning with global standards will not only bolster public trust but also position India as a leader in next-generation therapeutics. As part of international groups like the Quad and BRICS, India has the opportunity to expand its pharmaceutical leadership and enhance its soft diplomatic efforts.
Manjeera Gowravaram, a PhD in RNA biochemistry, provides insightful analysis on the intersection of science and policy.
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Many Floridians are discovering after major hurricanes that what they assumed was covered by their insurance simply isn’t. With more than 100,000 claims denied or closed without payment and widespread confusion over gaps like flood versus hurricane coverage, experts warn that the fine print can hit harder than the storm itself. As premiums rise and policies grow more complex, understanding what’s actually protected has become essential for homeowners and real estate professionals alike.
A new report from Zillow shows the U.S. just experienced its strongest October housing market since 2021, with inventory rising, affordability improving, and both new listings and pending sales up 5% year-over-year. Nineteen major markets now favor buyers—nine more than last year—as mortgage rates ease, inventory rebounds, and home values level off. For real estate professionals, especially in Florida, these shifts signal a market gaining momentum heading into 2025 and beyond.
Commercial real estate is heading into 2026 with major shifts in policy, technology, investment flows, and market fundamentals. From tightening capital sources and AI-driven decision-making to nationwide housing shortages and a looming wave of maturing debt, professionals across real estate, finance, insurance, and development must adapt quickly. These trends will shape opportunities, risks, and required skills in the year ahead—making strategic education and licensing upgrades more important than ever.
A major cyberattack on real‑estate data giant SitusAMC has triggered emergency responses across Wall Street, exposing sensitive loan records and legal documents tied to major banks like JPMorgan and Citigroup. While operations have been restored, the breach highlights critical weaknesses in third‑party vendors that support the nation’s real‑estate and mortgage infrastructure. Federal investigators and financial institutions are now racing to assess the fallout as experts warn of long‑term risks to the digital systems underpinning multi‑trillion‑dollar lending markets.
Australia’s commercial real estate sector is undergoing a major long‑term shift driven by hybrid work, booming logistics demand, sustainability priorities and evolving global capital flows. With the market projected to grow from USD 11.96 billion in 2024 to USD 21.03 billion by 2033, the biggest opportunities are emerging in industrial assets, ESG‑certified buildings, flexible workspaces and adaptive reuse projects. These trends echo changes developing in the U.S.—including Florida—making Australia a valuable case study for professionals watching the future of commercial real estate.
A new wave of chat‑driven AI tools is transforming how agents market properties by letting them edit listing photos simply by describing what they want changed. From removing clutter to adjusting lighting or staging entire rooms, professionals can now showcase a unit’s full potential long before it’s camera‑ready. This technology boosts efficiency for property managers, enhances buyer engagement through interactive visuals, and underscores the importance of transparency as AI becomes a core part of real estate marketing.
Biobanks, essential repositories of biological samples, are critical to the success of precision medicine. These collections of blood, DNA, and tissue samples, coupled with genetic data, form the backbone of research aimed at developing targeted therapies for diseases like cancer and diabetes. However, as highlighted in a recent 
While countries like the U.K., U.S., and Japan have comprehensive biobank regulations ensuring data protection and privacy, India’s framework remains fragmented. The absence of a single authority to regulate biobanks and the lack of penalties for misconduct create risks of ethical violations and undermine public confidence. As the 
